Tumor-Suppressor Gene Transmembrane Protein 98 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer

被引:5
|
作者
Wu, San-Gang [1 ]
Xu, Jing-Ying [2 ]
Lei, Jian [2 ]
Hu, Min [2 ]
Zhou, Juan [2 ]
机构
[1] Xiamen Univ, Dept Radiat Oncol, Xiamen Canc Ctr,Sch Med, Xiamen Key Lab Radiat Oncol,Affiliated Hosp 1, Xiamen 361003, Fujian, Peoples R China
[2] Xiamen Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Sch Med, Xiamen 361003, Fujian, Peoples R China
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2022年 / 27卷 / 07期
关键词
TMEM98; ovarian cancer; tumor suppressor; prognosis; VASCULOGENIC MIMICRY;
D O I
10.31083/j.fbl2707210
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Ovarian cancer (OC) is the most deadly tumor in gynecology and there is no effective biomarker for diagnosis and treatment. The role of Transmembrane Protein 98 (TMEM98) in ovarian cancer is still unclear. Methods: The expression and prognostic effect of TMEM98 in OC were analyzed using the public database. Cell Counting Kit-8 proliferation experiment, scratch experiment, Transwell invasion experiment, flow cytometry, TUNEL staining, and in vivo and vitro experiment were used. Results: TMEM98 was significantly downregulated in OC tissues and cell lines compared to the normal ovarian tissue and cells lines. In addition, patients with lower TMEM98 levels exhibited inferior survival. Low expression of the TMEM98 promoted proliferation, migration, invasion, vasculogenic mimicry, and inhibited apoptosis in OC cells. The expression of Caspase-3 was significantly downregulated and the expression of Bcl-2 was significantly increased in the silencing-TMEM98 group. Moreover, low expression of TMEM98 promotes OC development in vivo. Bioinformatics analysis showed that TMEM98 expression was negatively correlated with poly ADP-ribose polymerase expression. Conclusions: This study demonstrates that TMEM98 is low expressed in OC and impacts the prognosis of OC patients. TMEM98 inhibits proliferation and promotes apoptosis and finally exerts a certain tumor-suppressor effect on OC.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] CANCER-RESEARCH - NEW TUMOR-SUPPRESSOR GENE CAPTURED
    TRAVIS, J
    SCIENCE, 1993, 260 (5112) : 1235 - 1235
  • [22] ARF tumor-suppressor gene: A natural defense against cancer
    不详
    ONCOLOGY-NEW YORK, 1999, 13 (05): : 718 - 718
  • [23] Progesterone Receptor Is a Haploinsufficient Tumor-Suppressor Gene in Cervical Cancer
    Park, Yuri
    Baik, Seunghan
    Ho, Charles
    Lin, Chin-Yo
    Chung, Sang-Hyuk
    MOLECULAR CANCER RESEARCH, 2021, 19 (01) : 42 - 47
  • [24] The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control
    Sard, L
    Accornero, P
    Tornielli, S
    Della, D
    Bunone, G
    Campiglio, M
    Colombo, MP
    Gramegna, M
    Croce, CM
    Pierotti, MA
    Sozzi, G
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) : 8489 - 8492
  • [25] Characterization of Tumor-Suppressor Gene Inactivation Events in 33 Cancer Types
    Jia, Peilin
    Zhao, Zhongming
    CELL REPORTS, 2019, 26 (02): : 496 - +
  • [26] THE P53 TUMOR-SUPPRESSOR GENE IN BREAST-CANCER
    ELLEDGE, RM
    ALLRED, DC
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (01) : 39 - 47
  • [27] ALLELIC DELETION MAPPING OF PUTATIVE TUMOR-SUPPRESSOR GENE ON 17Q IN SPORADIC OVARIAN-CANCER
    CHEN, K
    HAN, H
    LI, S
    SCHWARTZ, PE
    YANGFENG, TL
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 282 - 282
  • [28] CPEB-2 is a tumor-suppressor gene in human breast cancer
    Lala, Peeyush K.
    Tordjman, Joshua
    Amiri, Mehdi
    Hasan, Asma
    Hess, David
    Majumder, Mousumi
    CANCER RESEARCH, 2018, 78 (13)
  • [29] THE P53 TUMOR-SUPPRESSOR GENE INHIBITS ANGIOGENESIS BY STIMULATING THE PRODUCTION OF THROMBOSPONDIN
    DAMERON, KM
    VOLPERT, OV
    TAINSKY, MA
    BOUCK, N
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 : 483 - 489
  • [30] GENE-THERAPY OF CANCER THROUGH RESTORATION OF TUMOR-SUPPRESSOR FUNCTIONS
    FRIEDMANN, T
    CANCER, 1992, 70 (06) : 1810 - 1817